PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 59 filers reported holding PROQR THRAPEUTICS N V in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $117,000 | -5.6% | 157,910 | -1.2% | 0.00% | – |
Q2 2022 | $124,000 | -82.3% | 159,796 | -79.4% | 0.00% | – |
Q1 2022 | $702,000 | -97.8% | 775,935 | -80.2% | 0.00% | -100.0% |
Q4 2021 | $31,346,000 | +9.1% | 3,913,394 | +14.0% | 0.01% | 0.0% |
Q3 2021 | $28,726,000 | +27.9% | 3,432,069 | +3.0% | 0.01% | +20.0% |
Q2 2021 | $22,462,000 | +2.6% | 3,332,570 | +0.6% | 0.01% | -16.7% |
Q1 2021 | $21,896,000 | +58.4% | 3,312,507 | +0.7% | 0.01% | +50.0% |
Q4 2020 | $13,822,000 | -13.0% | 3,291,035 | -0.8% | 0.00% | -20.0% |
Q3 2020 | $15,888,000 | -21.3% | 3,316,837 | -0.0% | 0.01% | -16.7% |
Q2 2020 | $20,176,000 | +10.6% | 3,318,374 | -0.1% | 0.01% | 0.0% |
Q1 2020 | $18,236,000 | -45.1% | 3,321,703 | -0.9% | 0.01% | -25.0% |
Q4 2019 | $33,200,000 | +73.5% | 3,350,192 | +0.8% | 0.01% | +33.3% |
Q3 2019 | $19,135,000 | -37.1% | 3,322,107 | -0.6% | 0.01% | -33.3% |
Q2 2019 | $30,424,000 | -37.9% | 3,343,322 | -5.3% | 0.01% | -40.0% |
Q1 2019 | $48,969,000 | -8.9% | 3,530,568 | +3.7% | 0.02% | -11.8% |
Q4 2018 | $53,748,000 | +33077.8% | 3,406,102 | +30489.2% | 0.02% | – |
Q3 2015 | $162,000 | -13.8% | 11,135 | -1.2% | 0.00% | – |
Q2 2015 | $188,000 | -54.9% | 11,273 | -40.8% | 0.00% | – |
Q1 2015 | $417,000 | +70.9% | 19,049 | +69.0% | 0.00% | – |
Q4 2014 | $244,000 | – | 11,270 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 748,861 | $6,815,000 | 2.37% |
Opus Point Partners Management, LLC | 138,461 | $1,260,000 | 1.86% |
RTW INVESTMENTS, LP | 3,722,950 | $33,879,000 | 1.81% |
Kerrisdale Advisers, LLC | 465,580 | $4,237,000 | 1.52% |
DAFNA Capital Management LLC | 261,521 | $2,380,000 | 0.90% |
SPHERA FUNDS MANAGEMENT LTD. | 470,000 | $4,277,000 | 0.58% |
Artal Group S.A. | 1,300,000 | $11,830,000 | 0.48% |
Orbimed Advisors | 1,382,502 | $12,581,000 | 0.20% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,000 | $511,000 | 0.19% |
ALTRINSIC GLOBAL ADVISORS LLC | 201,360 | $1,832,000 | 0.08% |